IQVIA Holdings Inc. Receives Consensus Rating of 'Moderate Buy' from Analysts

IQVIA Holdings Inc. (NYSE:IQV) has recently garnered attention from the investment community, receiving an average consensus rating of "Moderate Buy" from a total of twenty-one brokerage firms covering the stock, according to MarketBeat.com. Among these analysts, three have assigned a hold rating, while seventeen have rated the stock as a buy, and one has even given a strong buy rating.

The average price target over the next twelve months, as set by the analysts, stands at $255.71, suggesting a potential upside for investors looking at this stock.

Recent Analyst Reports on IQVIA

Several analysts have updated their views on IQVIA Holdings recently. Truist Financial adjusted their target price from $265.00 to $261.00, maintaining a "buy" rating in their report dated December 12. William Blair reiterated an "outperform" rating for IQVIA on December 11. Furthermore, Evercore ISI lowered its target price from $270.00 to $265.00, also keeping an "outperform" rating, as reported on October 8. Deutsche Bank Aktiengesellschaft similarly cut its price target from $270.00 to $265.00 while maintaining a "buy" rating on November 1. BTIG Research followed suit, reducing its target from $290.00 to $260.00 and reiterating a "buy" rating for the stock.

Current Stock Performance of IQVIA

As of Friday, shares of IQVIA opened at $204.54. The company has a 50-day moving average price of $199.71 and a 200-day moving average price of $221.06. Its financial ratios indicate a debt-to-equity ratio of 1.76, a current ratio of 0.81, and a quick ratio of 0.81. IQVIA's market capitalization is approximately $37.12 billion, with a price-to-earnings (PE) ratio reported at 26.84 and a price-to-earnings-growth (PEG) ratio of 2.14, alongside a beta value of 1.48. Over the past year, the stock has traded between a low of $187.62 and a high of $261.73.

Institutional Investment Activity

A number of institutional investors and hedge funds have been actively involved in buying and selling shares of IQVIA recently. For instance, Capital Performance Advisors LLP acquired a new position in the third quarter worth around $27,000. Park Place Capital Corp also purchased a new stake valued at $28,000. Additionally, Avior Wealth Management LLC significantly increased its holdings in IQVIA by 117.6% during the same quarter, ending up with 161 shares valued at $38,000. Synergy Asset Management LLC invested in a new position valued at $33,000 in the fourth quarter, while Assetmark Inc. boosted its stake by 612.5%, owning 228 shares worth $54,000 after buying 196 more shares recently. Notably, around 89.62% of IQVIA's stock is owned by hedge funds and other institutional investors.

Overview of IQVIA Holdings Inc.

IQVIA Holdings Inc. specializes in providing advanced analytics, technology solutions, and clinical research services tailored to the life sciences industry across various regions, including the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three primary segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Conclusion

While IQVIA Holdings Inc. has established a "Moderate Buy" consensus rating among analysts, potential investors may want to consider various factors and alternative investment opportunities before making a decision. Keeping abreast of further analyst insights and market developments could be beneficial.

IQVIA, stocks, analysis